We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+33.07%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$43M
AUM Growth
-$9.9M
Cap. Flow
-$604K
Cap. Flow %
-1.4%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWTX icon
1
Edgewise Therapeutics
EWTX
$4.28B
$16.7M 38.82%
1,030,161
ARVN icon
2
Arvinas
ARVN
$517M
$13.5M 31.38%
1,585,721
CRNX icon
3
Crinetics Pharmaceuticals
CRNX
$8.88B
$5.87M 13.64%
141,000
COGT icon
4
Cogent Biosciences
COGT
$6.68B
$3.6M 8.37%
250,765
RLYB icon
5
Rallybio
RLYB
$87.1M
$1.65M 3.83%
412,700
ALEC icon
6
Alector
ALEC
$167M
$1.01M 2.33%
339,569
PASG icon
7
Passage Bio
PASG
$15.5M
$702K 1.63%
87,426
-37,470
-30% -$261K
ITRM
8
DELISTED
Iterum Therapeutics
ITRM
-345,020
Closed -$343K

Similar funds

New Leaf Venture Partners's Q3 2025 Portfolio in Review

As of Q3 2025, New Leaf Venture Partners held 8 positions worth $43M, down 19% from $52.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

New Leaf Venture Partners's Q3 2025 filing shows 1 reduced and 1 closed positions. The largest sale was Iterum Therapeutics, an estimated $343K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners's biggest Q3 2025 reduction was Passage Bio, cutting an estimated $261K.
  • New Leaf Venture Partners fully exited Iterum Therapeutics in Q3 2025, selling an estimated $343K.
  • New Leaf Venture Partners's ten largest holdings make up 100% of its $43M portfolio in Q3 2025.
  • New Leaf Venture Partners opened 0 new positions and closed 1 in Q3 2025.
  • New Leaf Venture Partners's portfolio value fell 19% quarter-over-quarter to $43M.

Based on New Leaf Venture Partners's 13F filing for Q3 2025, filed 14 Nov 2025.